Cyclana Bio: redefining women’s health
Longevity Technology - 30-Oct-2025Using menstrual fluid, Cyclana builds tissue models to tackle endometriosis and chronic inflammation
Join the club for FREE to access the whole archive and other member benefits.
CEO and Co‑Founder of Cyclana Bio
Dr Léa Wenger is the CEO and Co‑Founder of the Cambridge‑based biotech Cyclana Bio. With a background in veterinary medicine and a PhD in neuroscience from Cambridge University, she brings extensive experience in therapeutic research from both academia and industry. Building on her work in epigenetics and disease modelling at Altos Labs, she is now focused on tackling the scientific and clinical challenges of endometriosis by creating advanced tissue‑level models to accelerate discovery and treatment.
Visit website: https://www.cyclanabio.com/team-1
See alsoDetails last updated 04-Nov-2025
Using menstrual fluid, Cyclana builds tissue models to tackle endometriosis and chronic inflammation